Global X S&P Biotech ETF (ASX:CURE)

ASX:CURE Holdings Information

ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are Moderna stock at 2.27%, Twist Bioscience at 1.99%, Natera at 1.85%, Halozyme Therapeutics at 1.74%, and Biogen at 1.67%.

• Total Holdings: 10
• Top 10 Percentage: 17.77%
• Asset Class: Equity
• ETF Category: Health Care
• Assets: 48.30M
• PE Ratio: 33.58

Top 25 Holdings

Updated Oct 27, 2026

Filter results

No.	Symbol	Name	Weight% Weight	Shares	Stock Price	% Change
1	MRNA	Moderna, Inc.	2.27%	3,658	221.72	-0.47%
2	TWST	Twist Bioscience Corporation	1.99%	3,952	152.78	-11.92%
3	NTRA	Natera, Inc.	1.85%	1,502	414.30	-4.98%
4	HALO	Halozyme Therapeutics, Inc.	1.74%	4,619	130.91	-0.21%
5	BIIB	Biogen Inc.	1.67%	2,354	253.62	1.59%
6	UTHR	United Therapeutics Corporation	1.67%	979	598.72	0.87%
7	AMGN	Amgen Inc.	1.66%	1,268	466.01	1.15%
8	SYRE	Spyre Therapeutics, Inc.	1.65%	5,706	96.56	-2.43%
9	ABBV	AbbVie Inc.	1.64%	1,977	294.89	1.41%
10	EXEL	Exelixis, Inc.	1.64%	8,504	69.39	4.82%

Data Source: Finnhub Last updated: Oct 27, 2026

ETF holdings data is provided by Finnhub. Holdings are typically published by the ETF issuer at the end of each trading day.

Update frequency:

Daily

Last checked:

Oct 30, 2026

Data Sources Report a data error